Rachelle W Johnson Selected Research

OSM-LIF Receptors

12/2021	HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer.
1/2021	HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rachelle W Johnson Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 01/2011
14	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2011
13	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2011
4	Hypoxia (Hypoxemia) 12/2021 - 06/2015
3	Carcinoma (Carcinomatosis) 01/2021 - 09/2011
2	Osteolysis 01/2021 - 02/2011
2	Osteoporosis 01/2017 - 11/2014
1	Humoral Hypercalcemia Of Malignancy 01/2021
1	Bone Resorption 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Carcinogenesis 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020
1	Infections 11/2014
1	Bone Diseases (Bone Disease) 04/2014

Drug/Important Bio-Agent (IBA)

9	Parathyroid Hormone-Related ProteinIBA 12/2021 - 02/2011
6	Messenger RNA (mRNA)IBA 01/2018 - 02/2011
5	CytokinesIBA 01/2022 - 06/2015
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2011
4	Oxygen (Dioxygen)IBA 12/2021 - 06/2015
3	Histone Deacetylase InhibitorsIBA 12/2021 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 04/2021 - 10/2016
3	Transcription Factors (Transcription Factor)IBA 10/2019 - 09/2011
2	OSM-LIF ReceptorsIBA 12/2021 - 01/2021
2	Histone Deacetylases (Histone Deacetylase)IBA 12/2021 - 01/2021
2	Histones (Histone)IBA 12/2021 - 01/2021
2	LigandsIBA 01/2021 - 12/2014
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 06/2015
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2011
2	Parathyroid Hormone (Parathormone)IBA 01/2017 - 11/2014
2	Transforming Growth Factor beta (TGF-beta)IBA 12/2014 - 02/2011
1	Leukemia Inhibitory FactorIBA 01/2022
1	Ciliary Neurotrophic Factor (CNTF)IBA 01/2022
1	Oncostatin MIBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	EphA2 ReceptorIBA 04/2021
1	A-factor (Streptomyces)IBA 01/2021
1	entinostat (MS 275)IBA 01/2021
1	Azacitidine (5 Azacytidine)FDA Link 01/2021
1	EnzymesIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2021
1	Hypoxia-Inducible Factor 1IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	OsteocalcinIBA 10/2020
1	Diphosphonates (Bisphosphonates)IBA 10/2019
1	GANT58IBA 10/2019
1	Cyclic AMP (AMP, Cyclic)IBA 01/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2017
1	Teriparatide (Parathar)FDA Link 01/2017
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 06/2015
1	ChemokinesIBA 06/2015
1	Lithium ChlorideIBA 12/2014
1	CateninsIBA 12/2014
1	Transcription Factor 7-Like 2 ProteinIBA 12/2014
1	UbiquitinIBA 04/2014
1	Calgranulin AIBA 04/2014
1	Hemoglobin AIBA 04/2014
1	S100 Calcium Binding Protein A6IBA 04/2014
1	RANK LigandIBA 12/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2012
1	Macrophage Colony-Stimulating FactorIBA 12/2012
1	NucleotidesIBA 09/2011
1	LuciferasesIBA 09/2011
1	GuanosineIBA 09/2011
1	Smoothened ReceptorIBA 02/2011
1	cyclopamineIBA 02/2011

Therapy/Procedure

5	Therapeutics 04/2021 - 11/2014
1	Drug Therapy (Chemotherapy) 01/2021
1	Lasers (Laser) 04/2014